News

Emmes announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus...

Ascelia Pharma AB is presenting a study in which Orviglance® (manganese chloride tetrahydrate, former working name Mangoral) was compared against a gadolinium-based contrast agent at one of the world’s largest radiology conference, RSNA, in Chicago, Illinois. Orviglance is a novel...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has today outlined predictions for the life sciences industry in 2022. The predictions come from three experts recently appointed by the Alliance to...

FedEx Express (FedEx), a subsidiary of FedEx Corp. and one of the world’s largest express transportation companies, has been named “Asia’s Best 3PLs for Vaccines” at the Asia Pacific Vaccine Excellence Awards 2021 (AVEA 2021). FedEx was selected as “Asia’s...

Novasep, a leading supplier of services and technologies for the life sciences industry, and McSAF, a French biotech based in Tours, specialized in bioconjugation tools to design innovative and efficient bio drugs for health and diagnostics, are pleased to...

Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional...

New Zealand has finally approved India-made vaccines, Covishield and Covaxin. The decision comes soon after Australia, New Zealand’s neighbour, recognised the two Indian vaccines last month. This means that Indian travellers vaccinated with these vaccines will not have to...